PPS admits falsifying record for a 2007 trial of Boehringer’s ‘female viagra’

US CRO PPS Clinical Research has admitted that an employee falsified patient record during a trial of Boehringer Ingelheim’s failed ‘female Viagra,’ Flibanserin.

According to a report in the St Louis Post-Dispatch​ – a PPS employee who worked on the 2007 trial altered records to suggest that a patient who dropped out of the programme in December had continued to participate and had even turned up for an examination the following June.

Jim Crowe III, a lawyer representing PPS, told the Missouri Court the employee's “serious health issues that led her to not perform her job properly and (she) did some things that rendered (her actions) difficult to detect."

PPS pled guilty and also admitted it had "corruptly influenced, obstructed, and impeded" an inspection by the US Food and Drug Administration (FDA) in May 2010 by providing false patient records and agreed to a $68,000 fine.

Related topics Clinical Development Phase III-IV

Related news

Show more

Related products

show more

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

Related suppliers

Follow us

Products

View more

Webinars